Sudden Death in Men Versus Women with Heart Failure

Area of Science:

• Cardiology
• Sex Differences in Medicine
• Heart Failure Research

Background:

• Sudden cardiac death (SCD) is a critical concern in heart failure (HF).
• Understanding sex-based disparities in SCD is crucial for effective patient management.
• Existing research often underrepresents women, limiting sex-specific insights.

Purpose of the Study:

• To review current knowledge on sex differences in SCD mechanisms within HF.
• To explore prevention and management strategies tailored to sex in HF patients.
• To highlight the need for sex-specific recommendations and further research.

Main Methods:

• Literature review of studies investigating sex differences in SCD and HF.
• Analysis of clinical trial data, considering sex-specific outcomes.
• Synthesis of information on hormonal, cellular, and remodeling factors influencing SCD risk.

Main Results:

• Women with HF have a better prognosis and lower SCD incidence than men.
• Sex hormones, calcium handling, and myocardial remodeling may explain these differences.
• Current treatments (HF drugs, ablation) show promise, but caution is advised for QT-prolonging drugs.
• Implantable cardioverter-defibrillator (ICD) efficacy may differ between sexes.
• Lack of sex-specific guidelines due to data scarcity and underrepresentation of women in trials.

Conclusions:

• Significant sex differences exist in SCD risk and outcomes among HF patients.
• Further investigation is essential for developing sex-specific risk stratification models.
• Advanced techniques like cardiac MRI, genetics, and personalized medicine are key for future evaluations.
• Addressing the underrepresentation of women in clinical trials is critical for advancing care.